T1	p 57 78	premenopausal women .
T2	p 178 201	against breast cancer .
T3	p 542 596	36 premenopausal women , 20 of whom used OC . Subjects
T4	p 1438 1470	premenopausal OC or non-OC users
T5	i 17 27	soy intake
T6	i 100 114	phytoestrogens
T7	i 118 121	soy
T8	i 243 246	soy
T9	i 485 499	contraceptives
T10	i 502 504	OC
T11	i 535 538	soy
T12	i 583 585	OC
T13	i 612 618	normal
T14	i 661 751	soy beverage containing 20 g of protein and 38 mg of total isoflavones to their usual diet
T15	i 971 974	soy
T16	i 1155 1158	soy
T17	o 31 53	sex hormone metabolism
T18	o 831 965	serum estrone , estradiol , sex hormone-binding globulin , dehydroepiandrosterone sulfate , prolactin , or progesterone concentrations
T19	o 975 982	feeding
T20	o 1026 1139	in menstrual cycle length or the urinary estrogen metabolite ratio of 2-hydroxyestrone to 16 alpha-hydroxyestrone
T21	o 1199 1237	Levels of urinary estrogen metabolites
T22	o 1359 1434	menstrual cycle , serum sex hormones , or urinary estrogen metabolite ratio